Get access

A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia

Authors

  • Florin Sasarman,

    1. Montreal Neurological Institute, McGill University, Montreal, Canada
    2. Department of Human Genetics, McGill University, Montreal, Canada
    Search for more papers by this author
  • Tamiko Nishimura,

    1. Montreal Neurological Institute, McGill University, Montreal, Canada
    2. Department of Human Genetics, McGill University, Montreal, Canada
    Search for more papers by this author
  • Isabelle Thiffault,

    1. Montreal Neurological Institute, McGill University, Montreal, Canada
    2. Department of Human Genetics, McGill University, Montreal, Canada
    Search for more papers by this author
  • Eric A. Shoubridge

    Corresponding author
    1. Montreal Neurological Institute, McGill University, Montreal, Canada
    2. Department of Human Genetics, McGill University, Montreal, Canada
    • Montreal Neurological Institute, 3801 University Street, Montreal, Quebec H3A 2B4, Canada.
    Search for more papers by this author

  • Communicated by Jan P. Kraus

Abstract

Mutations in the mitochondrial aminoacyl-tRNA synthetases (ARSs) are associated with a strikingly broad range of clinical phenotypes, the molecular basis for which remains obscure. Here, we report a novel missense mutation (c.137G>A, p.Gly46Asp) in the catalytic domain of YARS2, which codes for the mitochondrial tyrosyl-tRNA synthetase, in a subject with myopathy, lactic acidosis, and sideroblastic anemia (MLASA). YARS2 was undetectable by immunoblot analysis in subject myoblasts, resulting in a generalized mitochondrial translation defect. Retroviral expression of a wild-type YARS2 complementary DNA completely rescued the translation defect. We previously demonstrated that the respiratory chain defect in this subject was only present in fully differentiated muscle, and we show here that this likely reflects an increased requirement for YARS2 as muscle cells differentiate. An additional, heterozygous mutation was detected in TRMU/MTU1, a gene encoding the mitochondrial 2-thiouridylase. Although subject myoblasts and myotubes contained half the normal levels of TRMU, thiolation of mitochondrial tRNAs was normal. YARS2 eluted as part of high-molecular-weight complexes of ∼250 kDa and 1 MDa by gel filtration. This study confirms mutations in YARS2 as a cause of MLASA and shows that, like some of the cytoplasmic ARSs, mitochondrial ARSs occur in high-molecular-weight complexes. Hum Mutat 33:1201–1206, 2012. © 2012 Wiley Periodicals, Inc.

Get access to the full text of this article

Ancillary